DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Hybrid Metal-Phenol Nanoparticles with Polydopamine-like Coating for PET/SPECT/CT Imaging
The validation of metal-phenolic nanoparticles (MPNs) in preclinical imaging studies represents a growing field of interest due to their versatility in forming predesigned structures with unique properties. Before MPNs can be used in medicine, their pharmacokinetics must be optimized so that accumulation in nontargeted organs is prevented and toxicity is minimized. Here, we report the fabrication of MPNs made of a coordination polymer core that combines In(III), Cu(II), and a mixture of the imidazole 1,4-bis(imidazole-1-ylmethyl)-benzene and the catechol 3,4-dihydroxycinnamic acid ligands. Furthermore, a phenolic-based coating was used as an anchoring platform to attach poly(ethylene glycol) (PEG). The resulting MPNs, with effective hydrodynamic diameters of around 120 nm, could be further derivatized with surface-embedded molecules, such as folic acid, to facilitate in vivo targeting and multifunctionality. The prepared MPNs were evaluated for in vitro plasma stability, cytotoxicity, and cell internalization and found to be biocompatible under physiological conditions. First, biomedical evaluations were then performed by intrinsically incorporating trace amounts of the radioactive metals 111In or 64Cu during the MPN synthesis directly into their polymeric matrix. The resulting particles, which had identical physicochemical properties to their nonradioactive counterparts, were used to perform in vivo single-photon emission computed tomography (SPECT) and positron emission tomography (PET) in tumor-bearing mice. The ability to incorporate multiple metals and radiometals into MPNs illustrates the diverse range of functional nanoparticles that can be prepared with this approach and broadens the scope of these nanoconstructs as multimodal preclinical imaging agents., This work was supported by grant RTI2018-098027-B-C21 from the Spanish Government funds and by the European Regional Development Fund (ERDF). The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, funded by the Spanish Research Agency (AEI, grant no. SEV-2017-0706). Financial support from the University of Copenhagen, the Phospholipid Research Center (Heidelberg, Germany), and the Lundbeck Foundation (Copenhagen, Denmark) is kindly acknowledged. TRIUMF receives funding via a contribution agreement with the National Research Council of Canada. T.V.F.E. received financial support from a Killam Doctoral Fellowship and a Four-Year Doctoral Fellowship (4YF) from the University of British Columbia (UBC). K.S. acknowledges the generous support of BWXT Isotope Technology Group for the supply of the radioisotope 111In. The authors also thank the technicians and veterinarians at UBC Centre for Comparative Medicine (CCM, Vancouver, Canada), especially Dr. Laura Mowbray, Jana Hodasova, and Ava McHugh for their expert assistance in the imaging lab, and the Canada Foundation for Innovation (project no. 25413) for its support of the imaging facility (http://invivoimaging.ca/). S.S.-G. acknowledges the support from MINECO BES-2015-071492 grant. S.S.-G. and C.R.-R. acknowledge Dr. Pedro L. Esquinas for fruitful discussions about the quantitative measurements of 111In and 64Cu. Special thanks to Dr. Javier Saiz-Poseu from 3D Science Visuals (Instagram: 3dscivisuals) for contributing with graphic design and scientific illustrations. The authors acknowledge the support from the Cost ENBA CA15216.